Aveva Drug Delivery Systems, Inc. — Nicotine Transdermal System Patch recall — Low risk

Home › Medicine › Aveva Drug Delivery Systems, Inc.

Aveva Drug Delivery Systems, Inc.

Low risk

The FDA considers this unlikely to cause harm. Return it for a refund if you would rather not keep it.

Class III

Unlikely to cause any adverse health consequence, but the product breaks FDA rules.
Refunds don't require a receipt, and you don't need proof of purchase.
FDA status: Ongoing.

What was recalled

Source: FDA · synced 29 Jul 2026 13:14

Low risk Filed 2026-06-03

Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.

Check these codes: Lot #: 56841, Expires: 03/2028

59,808 pouches (4,272 Individual Folding Carton (IFC)) · distributed nationwide within the u.s Recall D-0550-2026 on FDA.gov ↗

Watch Aveva Drug Delivery Systems, Inc. for new recalls

One email per recall. Nothing else, ever.